We are live on ! Find out more
ICCM icon

IceCure Medical
ICCM

12 hedge funds and large institutions have $169K invested in IceCure Medical in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

43% more capital invested

Capital invested by funds: $118K → $169K (+$50.8K)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

20% less funds holding

Funds holding: 15 → 12 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$24.8K
2
TSS
Two Sigma Securities
New York
+$13K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.4K
4
Renaissance Technologies
Renaissance Technologies
New York
+$8.31K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$36.5K
2
Two Sigma Investments
Two Sigma Investments
New York
-$11.3K
3
VF
Virtu Financial
New York
-$9K
4
HF
HRT Financial
New York
-$8K
5
FIA
Foundations Investment Advisors
Arizona
-$6.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$64.8K +$24.8K +1,085 +124%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$44.5K +$11.4K +496 +58%
TSS
3
Two Sigma Securities
New York
$18.7K +$13K +567 New
Renaissance Technologies
4
Renaissance Technologies
New York
$12K +$8.31K +363 New
CIA
5
Concurrent Investment Advisors
Florida
$11K – – –
Morgan Stanley
6
Morgan Stanley
New York
$6.68K – – –
JP Morgan Chase
7
JP Morgan Chase
New York
$6.54K – – –
AW
8
Avion Wealth
Texas
$2K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$1K -$435 -19 -53%
Bank of America
10
Bank of America
North Carolina
$948 – – –
TRCT
11
Tower Research Capital (TRC)
New York
$323 – – –
BCWM
12
Bartlett & Co Wealth Management
Ohio
$275 – – –
SS
13
SBI Securities
Japan
$2 – – –
UBS Group
14
UBS Group
Switzerland
– -$36.5K -1,996 Closed
Two Sigma Investments
15
Two Sigma Investments
New York
– -$11.3K -618 Closed
VF
16
Virtu Financial
New York
– -$9K -486 Closed
HF
17
HRT Financial
New York
– -$8K -450 Closed
FIA
18
Foundations Investment Advisors
Arizona
– -$6.1K -333 Closed

ICCM Hedge Fund Activity: Q4 2024 in Review

12 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q4 2024, worth a combined $169K — up 43% from $118K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ICCM and 2 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $24.8K. The largest seller was UBS Group, exiting entirely with an estimated $36.5K sold.

  • 12 institutional investors held IceCure Medical (ICCM) as of Q4 2024, down from 15 in Q3 2024.
  • Funds reported $169K of IceCure Medical stock for Q4 2024, up 43% quarter-over-quarter.
  • 2 funds opened new IceCure Medical positions in Q4 2024 and 5 closed out, a net change of -3 holders.
  • The largest IceCure Medical buyer in Q4 2024 was XTX Topco, an estimated $24.8K added.
  • The largest IceCure Medical seller in Q4 2024 was UBS Group, an estimated $36.5K sold.

Based on aggregated 13F filings for Q4 2024.